Zoetis Inc. Long-Term Debt, Maturity, after Year Five
Zoetis Inc. (ZTS) had Long-Term Debt, Maturity, after Year Five of $4.55 billion as of 2021-03-31, per its 10-Q filed 2021-05-06.
Discontinued › Notes › Commitment and Contingencies
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive · last filed 2021-05-06
- 2021-03-31: Long-Term Debt, Maturity, after Year Five $4.55B.
- 2020-09-30: Long-Term Debt, Maturity, after Year Five $5.30B.
- 2020-06-30: Long-Term Debt, Maturity, after Year Five $5.30B.
- 2020-03-31: Long-Term Debt, Maturity, after Year Five $4.05B.
| Period end | Long-Term Debt, Maturity, after Year Five |
|---|---|
| 2021-03-31 | $4.55B 10-Q · filed 2021-05-06 |
| 2020-09-30 | $5.30B 10-Q · filed 2020-11-05 |
| 2020-06-30 | $5.30B 10-Q · filed 2020-08-06 |
| 2020-03-31 | $4.05B 10-Q · filed 2020-05-06 |
| 2019-09-30 | $4.05B 10-Q · filed 2019-11-07 |
| 2019-06-30 | $4.05B 10-Q · filed 2019-08-06 |
| 2019-03-31 | $4.05B 10-Q · filed 2019-05-02 |
| 2018-09-30 | $5.40B 10-Q · filed 2018-11-01 |
| 2018-06-30 | $4.50B 10-Q · filed 2018-08-02 |
| 2018-03-31 | $4.50B 10-Q · filed 2018-05-02 |
| 2017-12-31 | $4.50B 10-K · filed 2018-02-15 |
| 2017-10-01 | $4.50B 10-Q · filed 2017-11-02 |
| 2017-07-02 | $3.25B 10-Q · filed 2017-08-08 |
| 2017-04-02 | $3.25B 10-Q · filed 2017-05-04 |
| 2016-12-31 | $3.25B 10-K · filed 2017-02-16 |
| 2016-10-02 | $3.25B 10-Q · filed 2016-11-03 |
| 2015-12-31 | $3.75B 10-K · filed 2016-02-24 |
| 2014-12-31 | $2.50B 10-K · filed 2015-02-27 |
| 2013-03-31 | $3.25B 10-Q · filed 2013-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |